279 related articles for article (PubMed ID: 16405753)
1. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
[TBL] [Abstract][Full Text] [Related]
2. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
Liao DW; Wang L; Zhang XG; Liu MQ
Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Li L; Mei TH; Zhou XD; Zhang XG
Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
8. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
[TBL] [Abstract][Full Text] [Related]
9. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH
Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
[TBL] [Abstract][Full Text] [Related]
10. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R
Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer.
Ko E; Kim Y; Park SE; Cho EY; Han J; Shim YM; Park J; Kim DH
Lung Cancer; 2012 Aug; 77(2):401-6. PubMed ID: 22534667
[TBL] [Abstract][Full Text] [Related]
12. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
Chang C; Wang P; Yang H; Li L; Zhang LB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
[TBL] [Abstract][Full Text] [Related]
13. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
14. [The expression and clinical significance of AKT2, phosphorylated AKT2 in non-small cell lung cancer].
Pu R; Li WM; Liu D; Mo XM; Tang Y; Liu LX; Chen BJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):586-9. PubMed ID: 20848774
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
17. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
18. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
Wang WB; Cui YG; Yao SY
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
Zhang HZ; Wei YP; Li HG; Wang M; Liu JG; Wu C
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1307-10. PubMed ID: 16982442
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
